• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成年人多汗症的患病率和疾病负担。

Prevalence and disease burden of hyperhidrosis in the adult population.

机构信息

IVDP - Institute for Health Services Research in Dermatology and Healthcare, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Dermatology. 2013;227(1):10-3. doi: 10.1159/000351292. Epub 2013 Aug 27.

DOI:10.1159/000351292
PMID:23988406
Abstract

BACKGROUND

Although hyperhidrosis is a common and burdensome condition, little is known about the population-based prevalence.

OBJECTIVE

To evaluate the epidemiology, disease burden and medical care of hyperhidrosis in German adults.

METHODS

Employees of fifty-two companies underwent skin screenings and interviews including hyperhidrosis questions.

RESULTS

14,336 individuals were investigated (36% women, mean age 42 years) of whom 2,340 (16.3%) reported hyperhidrosis, including 869 (6.1%) with frequent or continuous disturbing sweating. 28% showed focal hyperhidrosis, whilst 68% had a generalized condition. Predictors of hyperhidrosis were male gender and concomitant drug medication. Moreover, persons with psoriasis and with metabolic comorbidity were at increased risk. Only 27% of those with focal hyperhidrosis had consulted a physician, and only 28% used prescribed medication or self-medication.

CONCLUSION

Hyperhidrosis is a frequent skin condition predicted by medical and personal factors. In spite of the disease burden, few individuals utilize medical care. Affected individuals should be encouraged to refer to a dermatologist.

摘要

背景

尽管多汗症是一种常见且令人痛苦的疾病,但人们对其在人群中的患病率知之甚少。

目的

评估德国成年人多汗症的流行病学、疾病负担和医疗保健情况。

方法

52 家公司的员工接受了皮肤筛查和访谈,其中包括多汗症相关问题。

结果

共有 14336 人接受了调查(36%为女性,平均年龄 42 岁),其中 2340 人(16.3%)报告患有多汗症,包括 869 人(6.1%)存在频繁或持续令人困扰的出汗。28%为局限性多汗症,68%为全身性多汗症。多汗症的预测因素为男性性别和同时使用药物治疗。此外,患有银屑病和代谢合并症的人患病风险增加。仅有 27%的局限性多汗症患者曾咨询过医生,只有 28%使用过处方药物或自行用药。

结论

多汗症是一种常见的皮肤疾病,受医疗和个人因素影响。尽管疾病负担沉重,但很少有人寻求医疗护理。应鼓励受影响的个体向皮肤科医生就诊。

相似文献

1
Prevalence and disease burden of hyperhidrosis in the adult population.成年人多汗症的患病率和疾病负担。
Dermatology. 2013;227(1):10-3. doi: 10.1159/000351292. Epub 2013 Aug 27.
2
Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees.银屑病的皮肤合并症:来自大规模员工队列的结果。
Arch Dermatol Res. 2017 Jul;309(5):349-356. doi: 10.1007/s00403-017-1741-4. Epub 2017 Apr 12.
3
[Hyperhidrosis as risk factor for tinea pedis].[多汗症作为足癣的危险因素]
Hautarzt. 2005 Feb;56(2):151-5. doi: 10.1007/s00105-004-0849-6.
4
Focal hyperhidrosis: diagnosis and management.局限性多汗症:诊断与管理
CMAJ. 2005 Jan 4;172(1):69-75. doi: 10.1503/cmaj.1040708.
5
An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis.一项关于15%氯化铝于2%水杨酸凝胶基质中治疗中重度原发性腋窝多汗症疗效的开放标签试验。
J Drugs Dermatol. 2009 May;8(5):477-80.
6
Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.A型肉毒杆菌毒素与外用20%氯化铝治疗中度至重度原发性局灶性腋窝多汗症的对比研究
J Drugs Dermatol. 2008 Mar;7(3):221-7.
7
A case of hyperhidrosis successfully treated with 20% aluminium chloride hexahydrate in 95% ethyl alcohol.一例多汗症患者经用20%六水合氯化铝溶于95%乙醇中治疗成功。
Singapore Med J. 1990 Feb;31(1):85-6.
8
[Investigation of tinea pedis and toenail onychomycosis prevalence in patients with psoriasis].[银屑病患者足癣和趾甲甲真菌病患病率的调查]
Mikrobiyol Bul. 2009 Jul;43(3):439-47.
9
Prevalence and Characteristics of Hyperhidrosis in Sweden: A Cross-Sectional Study in the General Population.瑞典多汗症的患病率及特征:一项针对普通人群的横断面研究
Dermatology. 2016;232(5):586-591. doi: 10.1159/000448032. Epub 2016 Sep 1.
10
US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.美国多汗症患病率及其对腋窝多汗症患者的影响:一项全国性调查结果
J Am Acad Dermatol. 2004 Aug;51(2):241-8. doi: 10.1016/j.jaad.2003.12.040.

引用本文的文献

1
Primary hyperhidrosis: an updated review.原发性多汗症:最新综述。
Drugs Context. 2025 Jun 16;14. doi: 10.7573/dic.2025-3-2. eCollection 2025.
2
Which patients are more likely to experience compensatory hyperhidrosis after endoscopic thoracic sympathectomy: a meta-analysis and systematic review.哪些患者在内镜下胸交感神经切除术后更易出现代偿性多汗症:一项荟萃分析与系统评价
PeerJ. 2025 Mar 18;13:e19097. doi: 10.7717/peerj.19097. eCollection 2025.
3
Impact of primary hyperhidrosis on patients' quality of life in Damietta governorates.
达米埃塔省原发性多汗症对患者生活质量的影响。
Arch Dermatol Res. 2025 Mar 12;317(1):551. doi: 10.1007/s00403-025-04034-z.
4
Arabic Translation, Cultural Adaptation, and Validation of the Hyperhidrosis Disease Severity Scale (Ar-HDSS).多汗症疾病严重程度量表(阿拉伯语版 - HDSS)的阿拉伯语翻译、文化调适及验证。
Healthcare (Basel). 2025 Feb 12;13(4):397. doi: 10.3390/healthcare13040397.
5
The Creation of the Arabic Version of the Hyperhidrosis Quality of Life Index (HidroQoL©) with Validation and Cross-Cultural Adaptation.多汗症生活质量指数阿拉伯语版本(HidroQoL©)的创建及效度验证与跨文化调适
Clin Cosmet Investig Dermatol. 2025 Jan 25;18:251-263. doi: 10.2147/CCID.S498688. eCollection 2025.
6
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis.继发性多汗症的病因及关键临床特征综述
Am J Clin Dermatol. 2025 Jan;26(1):97-108. doi: 10.1007/s40257-024-00908-6. Epub 2024 Nov 27.
7
Epidemiology and health care of hyperhidrosis in Germany: claims data analysis.德国多汗症的流行病学和医疗保健:索赔数据分析。
BMJ Open. 2024 Aug 12;14(8):e085862. doi: 10.1136/bmjopen-2024-085862.
8
The reliability and validity of a developed anxiety scale specific to primary focal hyperhidrosis symptoms.一种专门针对原发性局限性多汗症症状所开发的焦虑量表的信度和效度。
Biopsychosoc Med. 2024 Jun 4;18(1):14. doi: 10.1186/s13030-024-00310-y.
9
Topical Oxybutynin 3% Gel Versus Aluminum Chloride 15% Lotion in Treatment of Primary Focal Hyperhidrosis.3%奥昔布宁凝胶与15%氯化铝洗剂治疗原发性局灶性多汗症的对比研究
Dermatol Pract Concept. 2023 Jul 1;13(3):e2023192. doi: 10.5826/dpc.1303a192.
10
Onychomycosis: Old and New.甲癣:新旧情况
J Fungi (Basel). 2023 May 12;9(5):559. doi: 10.3390/jof9050559.